Revolutionary Test Offers Cancer Pts. Chance to Improve Outcomes 200%
September 01, 2022 15:48 ET
|
Integrative Cancer Centers of America
Newport Beach, California, United States , Sept. 01, 2022 (GLOBE NEWSWIRE) -- Every living cell has an enemy – Superman had Kryptonite, Nightwalkers had Dragonglass, and cancer has chemotherapy when...
Oncology Drugs Market Worth $848.94 Billion by 2030 at 9.51 % CAGR
August 29, 2022 14:37 ET
|
STRATEGIC MARKET RESEARCH LLP
New York,USA, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Oncology Drugs Market Worth $848.94 Billion by 2030 at 9.51 % CAGR The revenue of the Oncology Drugs Market was USD 177.54 Billion in 2021 and is...
Global Gynecological Cancer Drugs Market Report 2022: Advancement of Cancer Drug Research and the Advent of Personalized Medicine Presents Opportunities
August 25, 2022 05:53 ET
|
Research and Markets
Dublin, Aug. 25, 2022 (GLOBE NEWSWIRE) -- The "Gynecological Cancer Drugs Market By Therapeutic Modality, By Indication: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been...
Global Head & Neck Cancer Drugs Market (2022 to 2027) - Featuring AbbVie, Amgen and Gilead Sciences Among Others
August 24, 2022 05:08 ET
|
Research and Markets
Dublin, Aug. 24, 2022 (GLOBE NEWSWIRE) -- The "Global Head & Neck Cancer Drugs Market (2022-2027) by Drug Class, Product, End User, Geography, Competitive Analysis and the Impact of Covid-19...
Pet Cancer Therapeutics Market to hit USD 760 million by 2030, says Global Market Insights Inc.
August 16, 2022 03:15 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Aug. 16, 2022 (GLOBE NEWSWIRE) -- The pet cancer therapeutics market value is anticipated to be valued over USD 760 million by 2030. Rising awareness pertaining to pet diseases...
Global Oncology Drugs Market Report 2022-2027: Featuring Key Players F. Hoffmann-La Roche, Novartis, Bristol-Myers Squibb, Merck & Co, Johnson & Johnson, Pfizer & Others
August 12, 2022 07:48 ET
|
Research and Markets
Dublin, Aug. 12, 2022 (GLOBE NEWSWIRE) -- The "Global Oncology Drugs Market (2022-2027) by Drug Class, Indication, End-user, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff...
Conjugated Antibodies in Oncology Analytical Tool 2022: Must-have Reference Tool for Any Business Developer, BI/CI Operative or Clinical Developer
July 26, 2022 04:48 ET
|
Research and Markets
Dublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "Conjugated Antibodies in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering. Conjugated Antibodies in Oncology:...
Epirubicin Market Worth $243.99 Million, Globally, by 2028 at 3.6% CAGR - Exclusive Report by The Insight Partners
July 22, 2022 06:56 ET
|
The Insight Partners
New York, July 22, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Epirubicin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Dosage (10mg/Vial,...
Prostate Cancer Therapeutics Market to Expand at 6.9% CAGR during Forecast Period; Players Focus on Launching Effectual Therapies, States TMR Study
July 15, 2022 10:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, July 15, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc.: According to the prostate cancer therapeutics market outlook by Transparency Market Research...
Purple Biotech Announces Executive Leadership Changes
July 14, 2022 07:30 ET
|
Purple Biotech Ltd.
Gil Efron appointed as Chief Executive Officer Isaac Israel to transition to advisor role, continue as Board member REHOVOT, Israel, July 14, 2022 (GLOBE NEWSWIRE) -- Purple Biotech Ltd....